January 10, 2025 04:53 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
8 labourers still trapped in Assam's flooded mine even after 3 days of rescue ops | SC refuses to hear petitions seeking review of its same-sex marriage judgement, says there is 'no error' | 'They should wind up the alliance': Omar Abdullah on AAP-Congress fight over Delhi elections | Pune woman killed by her colleague in full public view for not paying back his money, no one intervenes | Los Angeles wildfire leaves 5 dead, forces 1 lakh including celebs to flee, Hollywood hills ablazed | PM Modi condoles death of six people in Tirupati stampede incident | Days after condemning Pak airstrikes, India in a first engages with Afghanistan's Taliban regime | 6 dead in stampede near Tirupati temple during token distribution to offer prayers | Prominent journalist-film producer Pritish Nandy dies of cardiac arrest at 73 | Thousands, including Hollywood stars, flee Los Angeles upscale neighbourhood as wildfire engulfs homes
India registers 64,531 fresh COVID-19 cases, 1092 deaths reported

India registers 64,531 fresh COVID-19 cases, 1092 deaths reported

Aug 19, 2020, at 03:49 pm

New Delhi: India registered  64,531 fresh COVID-19 cases in the past 24 hours, as per Ministry of Health data released on Wednesday.

Hetero launches first generic ‘ COVIFOR’ in India for Covid-19 treatment

Hetero launches first generic ‘ COVIFOR’ in India for Covid-19 treatment

Jun 21, 2020, at 08:24 pm

Hyderabad/UNI:  Hetero -- a generic pharmaceutical companies, on Sunday claimed that it has received the manufacturing and marketing approval for the investigational antiviral medicine ‘Remdesivir’ from the Drug Controller General of India (DCGI) for the treatment of Covid-19.